EMR

Business Context and Reporting Period

Company: Emerson Electric Co.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended December 31, 2003 (First Quarter of Fiscal 2004)
Business Overview: Emerson manufactures and distributes industrial automation, process control, electronics, HVAC, and appliance products. The quarter was characterized by strong sales growth driven by international markets, particularly Asia, and favorable currency translation, partially offset by weakness in U.S. capital goods markets.

Key Financial Metrics

Note: Total Debt calculated as Short-term borrowings ($647M) + Long-term debt ($3,733M) for Q1 2004.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 12% ($374 million) year-over-year. Underlying sales (excluding acquisitions, divestitures, and currency) grew 7%. International sales drove the majority of growth, with a 5.5 percentage point favorable impact from currency translation (primarily the Euro).
• Profitability: Net earnings rose 12% to $244 million. Operating margins improved due to leverage on higher sales volumes and prior rationalization efforts, though this was partially offset by increased pension and medical costs.
• Expense Increases: "Other deductions, net" increased $33 million to $78 million. This was driven by $33 million in rationalization costs (up $6 million), $9 million in litigation/disputed matters, and the absence of a $15 million divestiture gain recorded in the prior year.
• Cash Flow: Operating cash flow decreased 8% to $284 million due to increased working capital requirements to support higher sales. Free cash flow declined 11% to $217 million.
• Balance Sheet: Cash and equivalents increased by $313 million during the quarter. Total debt to total capital ratio improved to 39.4% from 43.4% in the prior year's first quarter.

Guidance, Outlook, and Risks

• Fiscal 2004 Guidance: Management expects diluted earnings per share in the range of $2.65 to $2.75 for the full fiscal year 2004.
• Expected Items: The company anticipates divestiture gains of $25 million to $35 million and rationalization costs of approximately $140 million for fiscal 2004.
• Subsequent Events: Following the quarter-end, the company sold its investment in the Louisville Ladder joint venture and 2 million shares of MKS Instruments, Inc., expecting a pretax gain of approximately $25 million in the second quarter.
• Risks and Contingencies:
  • Legislative Impact: The Medicare Prescription Drug, Improvement and Modernization Act of 2003 was signed into law; while the company does not expect a material impact, specific accounting guidance is pending.
  • Market Conditions: Continued weakness in U.S. capital goods markets constrains growth in commercial-based businesses.
  • Currency: Results are sensitive to exchange rate fluctuations, particularly the Euro and Asian currencies.

Investor Verification Checklist

• Currency Impact: Verify the sustainability of the 5.5 percentage point favorable currency impact on sales, as future exchange rate movements could reverse this benefit.
• Rationalization Costs: Monitor the execution of the $140 million in expected rationalization costs for fiscal 2004 to ensure they align with projected margin improvements.
• Divestiture Gains: Confirm the timing and realization of the expected $25 million to $35 million in divestiture gains, noting the $25 million gain from recent subsequent transactions.
• Pension Obligations: Review the funded status of the primary U.S. pension plan, which improved to $180 million, and monitor the impact of lower discount rates on future pension expenses.
• Working Capital: Assess the trend in working capital usage, which reduced operating cash flow by $127 million in the quarter, to ensure it does not become a persistent drag on liquidity.